Biotech/Biomedical
News Category
Instinct Bio Partners With INVITRX to Launch GENREVER in U.S. and Boost Indonesia Regenerative Medicine
Instinct Bio's collaboration with INVITRX aims to bring its GENREVER cosmetic brand to the U.S. market and support regenerative medicine initiatives i...
Alexandre B. de Moura, MD, and Timothy T. Roberts, MD, Named 2026 Castle Connolly Top Doctors
Two orthopaedic spine surgeons from New York Spine Institute have been recognized as Castle Connolly Top Doctors for the first time, highlighting thei...
BRAIN Biotech AG Appoints Dr. Sven K. Weber as New CEO, Succeeding Adriaan Moelker
Dr. Sven K. Weber will become CEO of BRAIN Biotech AG on October 1, 2026, succeeding Adriaan Moelker, who retires after six years; this leadership cha...
ZEAL Network SE Announces Earnings Call for Half-Year Report 2026
ZEAL Network SE invites investors, analysts, and journalists to its earnings call on August 5, 2026, to discuss the half-year results, highlighting th...
Regentis Biomaterials Targets $3 Billion Cartilage Repair Market with Cell-Free Gelrin C
Regentis Biomaterials is advancing its Gelrin C hydrogel as a scalable, off-the-shelf treatment for cartilage defects, aiming to address a $3 billion ...
VERAXA Biotech Expands Patent Portfolio to Protect Next-Generation Cancer Therapy Platforms
VERAXA Biotech (VRXA) filed new patent applications in 2025, expanding its portfolio to over 50 granted patents across 14 countries, aiming to protect...
MindBio Therapeutics Delivers First Edge AI Kiosks for Workplace Impairment Screening
MindBio Therapeutics has completed and delivered its first Edge AI Intoxication and Fatigue Detection Kiosk prototypes, aiming to provide rapid, scala...
NeuroThera Labs Validates Quantum Sampling Workflow for Clinical Data Analytics on S&P 500 Company Platform
NeuroThera Labs has internally validated a proprietary quantum sampling workflow that enables continuous clinical data to be represented and analyzed ...
American Fusion Begins Texatron Testing Program at Texas Tech, Advancing Neutronic Fusion Platform
American Fusion Inc. has started testing its Texatron Fusion Engine at Texas Tech University, marking a key step toward modular, infrastructure-grade ...
Datavault AI Expands DataMEDS Licensing Agreement into Commercial Healthcare, Enabling Patient-Controlled Data Models
Datavault AI Inc. (NASDAQ: DVLT) expands its DataMEDS licensing agreement to extend blockchain-based technology into commercial healthcare, healthspan...
Why the Fed Vote Tally Matters More Than the Decision
The article explains that the vote tally from the FOMC meeting is more insightful than the rate decision itself, as it reveals internal divisions and ...
VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Advance BiTAC(R) Cancer Therapy Platform
VERAXA Biotech strengthens its scientific leadership with Dr. Christoph Erkel as CSO, advancing its proprietary BiTAC(R) platform toward clinical deve...
VERAXA Biotech Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms
VERAXA Biotech AG has expanded its intellectual property portfolio with new patent filings for its BiTAC-TCE and BiTAC-ADC platforms, strengthening it...
American Fusion Appoints Alec Rossa as Chief Revenue Officer as Texatron Development Advances
American Fusion Inc. has appointed a Chief Revenue Officer to lead commercialization of its fusion technology, which is progressing through testing, r...
Nearly 23 Million U.S. Adults May Be Newly Eligible for Blood Pressure Medication Under 2025 Guideline
A new study published in the Journal of the American Heart Association estimates that 28% of U.S. adults with high blood pressure may be newly eligibl...
Plastic Surgeon Dr. Edward H. Davidson Named a 2026 Castle Connolly Top Doctor
Dr. Edward H. Davidson, a board-certified plastic surgeon specializing in facial reconstruction and rejuvenation, has been recognized as a 2026 Castle...
Greenland Mines Secures Canadian Patent for Klotho Gene Therapy Technology Targeting Neurodegenerative Diseases
Greenland Mines (GRML) received a Canadian patent for Klotho-based gene therapies targeting Alzheimer's, Parkinson's, ALS, and multiple sclerosis, exp...
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials While Expanding Commercial Revenue Streams
Quantum BioPharma's executive outlines the development strategy for Lucid-MS, a potential multiple sclerosis treatment entering Phase 2 trials, alongs...
VERAXA Biotech Shareholders Overwhelmingly Approve Corporate Governance and Financing Measures
VERAXA Biotech shareholders approved proposals to enhance corporate flexibility for growth, including a capital band and expanded board, with over 99....
NowMedia Television Networks and Dr. Nathan S. Bryan Launch 'Your Optimal Health' to Demystify Health Science
A new bilingual TV program aims to translate complex nitric oxide and cardiovascular research into practical health advice, empowering viewers to make...
Regentis Biomaterials Advances GelrinC Toward Key Clinical and Regulatory Milestones in Cartilage Regeneration
Regentis Biomaterials is progressing its GelrinC hydrogel implant through pivotal clinical and regulatory stages, with strategic market validation fro...
Greenland Mines Secures Canadian Patent for Klotho Gene Therapy Technology
Greenland Mines Ltd. received a Canadian patent for Klotho-based gene therapies targeting neurodegenerative diseases, expanding its IP portfolio and a...
Industry Push for Uniform Functional Safety Language Gains Momentum with TSMC's Involvement
The semiconductor industry is moving toward a standardized language for functional safety, driven by key players like TSMC, to streamline design and d...
Autoantibodies May Hold Key to Cancer Risk and Immune Response, Researchers Propose
Scientists plan to investigate how autoantibodies influence cancer risk and immune response, potentially explaining why some individuals with risk fac...
Silver Prices Rise as Geopolitical Uncertainty Fuels Precious Metals Demand
Silver prices strengthened on Wednesday as geopolitical uncertainty shifted investor sentiment toward precious metals, with implications for mining co...
Gaxos.ai Outlines Post-Divestiture Strategy Focused on AI and Health Businesses
Gaxos.ai Inc. announced a strategic shift toward AI applications and health and wellness after selling its gaming assets, with first-quarter revenue r...
NextPlat Corp. Reports Mid-Year Progress Toward Profitability with Record Margins and Cash Position
NextPlat Corp. announced mid-year progress in its strategic turnaround, achieving record consolidated gross margins of 35%, over $11 million in cash, ...
NanoViricides Awaits Regulatory Decision on Ebola Trial for NV-387 Oral Gummies
NanoViricides seeks regulatory approval to begin a Phase II trial of its oral NV-387 gummies for Bundibugyo ebolavirus in the DRC, where no approved t...
Lantern Pharma's LP-184 Cleared by EMA for Bladder Cancer Trial in Europe
The EMA clearance allows Lantern Pharma to initiate a biomarker-guided Phase 1b/2 trial of LP-184 in advanced bladder cancer patients, advancing its A...
Nightfood Holdings Featured in AINewsWire Editorial Highlighting Evolution of Connected Robotics
Nightfood Holdings, operating as TechForce Robotics, was featured in an AINewsWire editorial discussing the shift from standalone robots to coordinate...
Earth Science Tech Leverages Vertical Integration for Dilution-Free Growth
Earth Science Tech Inc. (ETST) is capitalizing on its vertically integrated healthcare platform—combining compounding pharmacies RxCompoundStore and M...
LataMed AI Partners with Two Caracas Schools to Expand Telemedicine Access
LataMed AI has signed agreements with Colegio Claret and Colegio Roraima in Caracas to develop school-based digital healthcare programs, aiming to con...
NeuroOne Reports Physician Experience Shows Potential Paradigm Shift in Epilepsy Treatment with OneRF Ablation System
Real-world evidence from a large cohort at Mayo Clinic suggests NeuroOne's OneRF Brain Ablation System, combined with diagnostic SEEG, can improve sei...
Mitch Gould's Four-Decade Journey from Brooklyn to Retail Giants
Mitch Gould's career, rooted in family business lessons, has shaped the Evolution of Distribution® model, helping brands enter major retailers like Wa...
Renaissance BioScience Receives Genome BC Funding to Extend RNAi Biopesticide Platform to Target Soil-Dwelling Crop Pests
Renaissance BioScience will use Genome BC funding to adapt its yeast-based RNAi biopesticide technology for soil-dwelling wireworms, potentially openi...
David Ferrera Urges Focus on Translational Discipline Over Breakthroughs in Medical Device Innovation
David Ferrera, CEO of RC Medical, argues that medical device innovation fails more often due to neglecting workflow and user needs than weak science, ...
High-Pressure Glass Autoclaves Market to Reach USD 355 Million by 2036, Driven by Research Visibility Needs
The global high-pressure glass autoclaves market is projected to grow from USD 162 million in 2026 to USD 355 million by 2036 at an 8.2% CAGR, fueled ...
Flow Cytometry Diagnostics Market Set to Reach USD 3.5 Billion by 2036 Driven by MRD Testing and Multiparametric Analysis
The flow cytometry diagnostics market is projected to grow from USD 1.5 billion in 2026 to USD 3.5 billion by 2036, driven by rising demand for hemato...
GeoVax Reports Second Quarter 2026 Financial Results and Advances GEO-MVA Toward Pivotal Immunobridging Study
GeoVax Labs reports progress on its GEO-MVA vaccine program toward a pivotal immunobridging study under an expedited regulatory pathway, while advanci...
VERAXA Biotech Advances Bispecific ADC Program VXA-222 Under OmniAb Collaboration
VERAXA Biotech announces the advancement of its bispecific antibody-drug conjugate program VXA-222 after OmniAb completes discovery work, moving the c...
Quantum BioPharma Advances Lucid-MS and Commercial Products, Executive Details Strategy in Podcast
Quantum BioPharma's executive outlines plans for Lucid-MS Phase 2 trial and commercial growth with unbuzzd, highlighting a dual strategy combining cli...
Onco-Innovations Advances ONC010 Toward Clinical Studies, Strengthening Its Oncology Pipeline
Onco-Innovations is progressing its lead cancer drug candidate ONC010, a PNKP inhibitor, by scaling up manufacturing and establishing partnerships to ...
Regentis Biomaterials Pioneers Cartilage Repair with GelrinC in Growing $3 Billion Market
Regentis Biomaterials is advancing its off-the-shelf cartilage regeneration platform GelrinC, targeting a $3 billion U.S. market and offering a simpli...
Earth Science Tech Reports Fiscal 2026 Growth, Advances Integrated Healthcare Platform
Earth Science Tech Inc. reported fiscal year 2026 results with revenue up 8% to $35.7 million, highlighting its progress in building a vertically inte...
Traditional Navajo Medically Tailored Meals Reduce Heart Failure Hospitalizations
A clinical trial showed that a culturally tailored food-is-medicine program incorporating traditional Navajo foods reduced all-cause hospitalizations ...
Gold Extends Drop as Traders Await Fed Meeting Amid Inflation Concerns
Gold prices continue to fall as energy-driven inflation raises expectations of a Federal Reserve interest rate hike, impacting mining companies like N...
Experimental Immunotherapy Shows Promise for Pediatric Brain Cancer
Research in Nature Medicine indicates experimental immunotherapy may offer new hope for children with aggressive brain and spinal cord tumors, which c...
American Fusion Highlights Texatron Technology and GEM Theory at APS Particle Physics Conference
American Fusion Inc. presented its Texatron Fusion Engine technology and GEM Unification Theory at the APS Division of Particles and Fields 2026 Meeti...